Influence of itraconazole co-administration and CYP2D6 genotype on the pharmacokinetics of the new antipsychotic ARIPIPRAZOLE.

Drug metabolism and pharmacokinetics

Volumn 20, Issue 1, 2005, Pages 55-64

  Kubo, Masanori ^a   Koue, Toshiko ^a   Inaba, Atsuhiro ^a   Takeda, Hiroshi ^a   Maune, Hiromi ^a   Fukuda, Tsuyoshi ^a   Azuma, Junichi ^a  

^a OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ARIPIPRAZOLE; CYP3A PROTEIN, HUMAN; CYP3A4 PROTEIN, HUMAN; CYTOCHROME P450; CYTOCHROME P450 2D6; ITRACONAZOLE; NEUROLEPTIC AGENT; PIPERAZINE DERIVATIVE; QUINOLONE DERIVATIVE;

ADULT; ARTICLE; BLOOD; GENETICS; GENOTYPE; HUMAN; MALE; METABOLISM; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADULT; ANTIFUNGAL AGENTS; ANTIPSYCHOTIC AGENTS; CYTOCHROME P-450 CYP2D6; CYTOCHROME P-450 ENZYME SYSTEM; GENOTYPE; HUMANS; ITRACONAZOLE; MALE; PIPERAZINES; QUINOLONES;

EID: 24144468204     PISSN: 13474367     EISSN: None     Source Type: Journal    
DOI: 10.2133/dmpk.20.55     Document Type: Article

References (0)